DGX

SEC source: 0001022079-24-000030 · wk-form4_1708131743.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,828

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-24-000029 · wk-form4_1708131707.xml · derivative · entry 3

Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,939

Underlying: Common Stock · 17,939 shares

Expires 2034-02-14

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-24-000029 · wk-form4_1708131707.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,114

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-24-000028 · wk-form4_1708131666.xml · derivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,322

Underlying: Common Stock · 2,322 shares

Expires 2034-02-14

F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-24-000028 · wk-form4_1708131666.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,070

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-24-000017 · wk-form4_1706910033.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,829

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-24-000015 · wk-form4_1706909908.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,510

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-24-000013 · wk-form4_1706909795.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,438

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-24-000011 · wk-form4_1706909646.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,589

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-24-000002 · wk-form4_1704403333.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,581.654

Underlying: Common Stock · 294 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000165 · wk-form4_1698358671.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,741

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the Reporting Person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The Reporting Person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-23-000164 · wk-form4_1698358629.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,358

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-23-000163 · wk-form4_1698358589.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,492

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000162 · wk-form4_1698358531.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,493

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-23-000149 · wk-form4_1696457096.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,205.584

Underlying: Common Stock · 344 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000145 · wk-form4_1695851649.xml · nonDerivative · entry 1

GARDNER MARK A · CIK 0001955242 · SVP of Molecular Gen & Oncol

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,805

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

SEC source: 0001022079-23-000141 · wk-form4_1692304787.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,294

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-23-000139 · wk-form4_1690490619.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,355

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000138 · wk-form4_1690490465.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,649

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-23-000137 · wk-form4_1690490433.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,397

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000126 · wk-form4_1689626237.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,475

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-23-000124 · wk-form4_1688589534.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,793.404

Underlying: Common Stock · 297 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000115 · wk-form4_1684534851.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,092

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000112 · wk-form4_1684534651.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,506

F1 · security: Represents an award of restricted stock units.

SEC source: 0001022079-23-000118 · wk-form4_1684535101.xml · nonDerivative · entry 1

Diaz Luis · CIK 0001720081 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,369

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-23-000117 · wk-form4_1684535036.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,571

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-23-000116 · wk-form4_1684534953.xml · nonDerivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,744

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000113 · wk-form4_1684534709.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,839

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000114 · wk-form4_1684534791.xml · nonDerivative · entry 1

Doi Tracey · CIK 0001527766 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,621

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000109 · wk-form4_1684534493.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,955

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-23-000108 · wk-form4_1684534406.xml · nonDerivative · entry 1

MAIN TIMOTHY L · CIK 0001196744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,612

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-24-000004 · wk-form5_1705702331.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,339

F1 · shares: Represents a charitable gift.

SEC source: 0001022079-23-000087 · wf-form4_168245940323748.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,319

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000085 · wf-form4_168245926446885.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,295

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000083 · wf-form4_168245913854661.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,202

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-23-000076 · wf-form4_168064049028656.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,431.114

Underlying: Common Stock · 291 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · balance_after: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

SEC source: 0001022079-23-000074 · wf-form4_167994954538049.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,258

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-23-000073 · wf-form4_167994948437526.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,480

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-23-000070 · wf-form4_167831157762872.xml · nonDerivative · entry 3

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,527

F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 27, 2022.

SEC source: 0001022079-23-000069 · wf-form4_167831147773831.xml · nonDerivative · entry 3

Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,810

F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022.

SEC source: 0001022079-23-000070 · wf-form4_167831157762872.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,281

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

SEC source: 0001022079-23-000070 · wf-form4_167831157762872.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,122

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-23-000068 · wf-form4_167831140057825.xml · nonDerivative · entry 2

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,357

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000068 · wf-form4_167831140057825.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,145

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-23-000069 · wf-form4_167831147773831.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,117

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

SEC source: 0001022079-23-000069 · wf-form4_167831147773831.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,727

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-23-000067 · wf-form4_167831132940620.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,497

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-23-000067 · wf-form4_167831132940620.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,178

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-23-000065 · wf-form4_167831106431713.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,634

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

SEC source: 0001022079-23-000065 · wf-form4_167831106431713.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,670

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).